Table 2

XRCC1 Arg399Gln, XRCC3 Thr241Met, XPD Lys751Gln polymorphisms and bladder cancer risk

GenotypeCases (%)Controls (%)ORa (95% CI)
XRCC1 codon 399
Arg/Arg93 (46)92 (43)Ref.
Arg/Gln87 (43)98 (46)0.87 (0.58–1.30)
Gln/Gln21 (11)24 (11)0.86 (0.45–1.66)
Arg/Gln, Gln/Gln108 (54)122 (57)0.86 (0.59–1.28)
XRCC3 codon 241
Thr/Thr89 (44)71 (33)Ref.
Thr/Met87 (43)116 (54)0.60 (0.40–0.91)
Met/Met25 (12)27 (13)0.74 (0.39–1.38)
Thr/Met, Met/Met112 (55)143 (67)0.63 (0.42–0.93)
XPD codon 751
Lys/Lys79 (39)80 (37)Ref.
Lys/Gln87 (43)98 (46)0.89 (0.58–1.36)
Gln/Gln35 (18)36 (17)1.00 (0.57–1.75)
Lys/Gln, Gln/Gln122 (61)134 (63)0.92 (0.62–1.37)
  • a Adjusted for age in unconditional logistic regression.